A61K 31/517
Ortho- or peri-condensed with carbocyclic ring systems
Official title: ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
A61K31/517 (Ortho- or peri-condensed with carbocyclic ring systems) appears on 2,412 US grants and 5,073 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,412
- Published applications
- 5,073
- Assignees
- 1,827
- Inventors
- 10,751
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 8 | 0 |
| 1997 | 11 | 0 |
| 1998 | 20 | 0 |
| 1999 | 17 | 0 |
| 2000 | 24 | 0 |
| 2001 | 28 | 10 |
| 2002 | 28 | 52 |
| 2003 | 28 | 71 |
| 2004 | 24 | 80 |
| 2005 | 21 | 101 |
| 2006 | 32 | 98 |
| 2007 | 16 | 95 |
| 2008 | 22 | 103 |
| 2009 | 21 | 109 |
| 2010 | 38 | 143 |
| 2011 | 45 | 161 |
| 2012 | 62 | 142 |
| 2013 | 80 | 214 |
| 2014 | 128 | 277 |
| 2015 | 166 | 305 |
| 2016 | 164 | 282 |
| 2017 | 200 | 278 |
| 2018 | 174 | 229 |
| 2019 | 172 | 261 |
| 2020 | 168 | 253 |
| 2021 | 124 | 263 |
| 2022 | 135 | 289 |
| 2023 | 93 | 308 |
| 2024 | 125 | 361 |
| 2025 | 125 | 324 |
| 2026 | 106 | 264 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses6 Oct 2026US 12,753,187 B2Merck Sharp & Dohme Corp.
- Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations29 Sep 2026US 12,746,268 B2Nymox Corporation
- Methods for the treatment of cancers that have acquired resistance to kinase inhibitors22 Sep 2026US 12,740,979 B2Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Method and composition for treating pain15 Sep 2026US 12,734,172 B2Academia Sinica
- KRas inhibitors1 Sep 2026US 12,723,053 B2Eli Lilly and Company
- Methods and compositions for treating inflammatory and fibrotic pulmonary disorders8 Oct 2026US 2026/0306493 A1Board of Regents, The University of Texas System
- Ketamine for the treatment of menstrually related symptoms1 Oct 2026US 2026/0294843 A1
- Methods for treating gastrointestinal inflammatory diseases using alpha-ketoglutarate (akg) modulators1 Oct 2026US 2026/0294856 A1
- Pharmaceutical composition for the treatment of post-traumatic stress syndrome1 Oct 2026US 2026/0294883 A1Kinnov Therapeutics
- Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan1 Oct 2026US 2026/0294894 A1Ipsen Biopharm Ltd.
Most cited
By later US patents
- 6-amino-1,4-dihydro-benzo[d][1,3] oxazin-2-ones and analogs useful as progesterone receptor modulators251US 7,247,625 B2Wyeth · 2007
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995
- Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase198US 5,710,158 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1998
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase171US 5,646,153 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1997